340binformed.org

Your Free Source for 340B News and Commentary

Key 340B Services Likely Would Remain Accessible During a Federal Shutdown

340B database and Regulations.gov portal stayed open during last shutdown in 2013 

September 18, 2015—For the second time in two years, a spending disagreement in Congress could force the government to shut down on the first day of October – which also is the start of one of the four 15-day periods per year for healthcare providers to enroll in the 340B drug discount program. … [Read more...]

Drugmakers Comment on 340B Pricing and Monetary Penalty Proposed Rule

PhRMA and BIO urge HRSA to make revisions 

September 16, 2015—The two major associations of brand-name drugmakers have issues with a proposed 340B program rule setting standards for calculating ceiling prices and implementing civil monetary penalties for drugmakers that knowingly and intentionally overcharge for 340B drugs.  … [Read more...]

Drugmaker Acknowledges Overcharging 340B Entities

Heritage Pharmaceuticals says purchases going back six years are affected 

September 15, 2015—Heritage Pharmaceuticals, a U.S.-based generic-drug manufacturer owned by the Indian drugmaker Emcure, has posted a notice on the 340B drug pricing program website stating it "recently determined that 340B pricing to participating 340B covered entities was not extended on purchases of its products made between April 18, 2008 and December 31, 2014." … [Read more...]

340B Program Director Pedley Promoted to Captain

USPHS commissioned officer has led drug discount program since 2010 

September 9, 2015—Krista Pedley, the U.S. Public Health Service Commissioned Officer in charge of the 340B drug discount program, has been promoted from Commander to Captain. … [Read more...]